Chest Pain

Acute CV hospitalizations and cardiac catheterization laboratory activations have declined during the COVID-19 pandemic, two studies found.

Incorporating a question about physical activity with coronary artery calcium scoring improved prediction of clinical and mortality risk in older patients, researchers reported.

CD34+ cell therapy in patients with coronary microvascular dysfunction improved coronary flow reserve in addition to angina class and symptoms at 6 months, according to data from the ESCaPE-CMD trial.

Among patients admitted to the hospital with acute MI and spontaneous coronary artery dissection, more than 12% are readmitted within 30 days of discharge, and half of readmissions within 1 week were for cardiac causes.

Despite having less ischemia and less extensive CAD compared with men, women had more frequent angina, according to new data from the ISCHEMIA trial.

In the randomized E3 trial, nicotine e-cigarettes combined with individual counseling was more effective for smoking cessation at 12 weeks than non-nicotine e-cigarettes with counseling or counseling alone.

Patients with hypertension and early postinfarction angina who underwent daily music therapy combined with the usual care reported less anxiety and chest pain than similar patients who received the usual care alone.

Among patients with laboratory-confirmed COVID-19 in Wuhan, China, those with cardiac injury had a higher risk for in-hospital mortality than patients without cardiac injury.

For most people, the evidence supports that regular exercise confers CV benefits, but some forms of extreme endurance exercise can be harmful to those unable to handle them, according to a scientific statement from the American Heart Association.

After the Hospital Readmission Reduction Program was implemented, declines were seen in 30-day readmission rates for both black and nonblack patients with MI, according to an observational cohort analysis published in JAMA Cardiology.